Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ISIS-PHARMACEUTICALS-INC-9734/news/Isis-Pharmaceuticals-Reports-Positive-Data-From-ISIS-TTR-Rx-in-Patients-With-TTR-Amyloidosis-20238853/?utm_source=whatsapp&utm_medium=social&utm_campaign=share